Nephros (NEPH) EBITDA Margin Growth (1y) (2011 - 2026)
Nephros (NEPH) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -321.00 |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -658.00 |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -315.00 |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 192.00 |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 563.00 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -331.00 |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -2,844.00 |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 26.00 |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -495.00 |
| 10 | Nephros | 34.19 Mn | 30.17 Mn | 2.99 Mn | -974.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -974.00 |
| Dec 31, 2025 | -781.00 |
| Sep 30, 2025 | 74.00 |
| Jun 30, 2025 | 1,536.00 |
| Mar 31, 2025 | 1,640.00 |
| Dec 31, 2024 | 2,829.00 |
| Sep 30, 2024 | 1,072.00 |
| Jun 30, 2024 | 247.00 |
| Mar 31, 2024 | 348.00 |
| Dec 31, 2023 | 543.00 |
| Sep 30, 2023 | 12,926.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 8,297.00 |
| Dec 31, 2022 | 1,295.00 |
| Sep 30, 2022 | -8,657.00 |
| Jun 30, 2022 | 739.00 |
| Mar 31, 2022 | -7,140.00 |
| Dec 31, 2021 | 411.00 |
| Sep 30, 2021 | 280.00 |
| Jun 30, 2021 | 5,921.00 |